The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA1331080
Max Phase: Preclinical
Molecular Formula: C14H17N5
Molecular Weight: 255.32
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: NC1=NC2(CCCCC2)n2c(nc3ccccc32)N1
Standard InChI: InChI=1S/C14H17N5/c15-12-17-13-16-10-6-2-3-7-11(10)19(13)14(18-12)8-4-1-5-9-14/h2-3,6-7H,1,4-5,8-9H2,(H3,15,16,17,18)
Standard InChI Key: WJHPMVORJRMNFR-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 255.32Molecular Weight (Monoisotopic): 255.1484AlogP: 2.39#Rotatable Bonds: 0Polar Surface Area: 68.23Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 7.96CX LogP: 3.04CX LogD: 2.38Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.76Np Likeness Score: -0.46
References 1. PubChem BioAssay data set, 2. Soliman AM, Mohamed SK, El Remaily MA, Abdel-Ghany H.. (2012) Synthesis and biological activity of dihydroimidazole and 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazins., 47 [PMID:22093758 ] [10.1016/j.ejmech.2011.10.034 ] 3. Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.. (2016) Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome., 59 (2): [PMID:26700945 ] [10.1021/acs.jmedchem.5b01631 ]